Takeda Pharmaceutical Company Limited Other Comprehensive Income
Takeda Pharmaceutical Company Limited (TKPHF) reported Other Comprehensive Income of -JPY 165.84 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncome · last filed 2025-06-25
| Period end | Other Comprehensive Income 12 month | Other Comprehensive Income 12 month as first filed |
|---|---|---|
| 2025-03-31 | -165.84B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 995.01B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 594.53B JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 594.26B JPY 20-F · filed 2024-06-26 | |
| 2021-03-31 | 321.25B JPY 20-F · filed 2023-06-28 | |
| 2020-03-31 | -243.71B JPY 20-F · filed 2022-06-29 | |
| 2019-03-31 | -13.48B JPY 20-F · filed 2021-06-29 | -9.82B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 55.96B JPY 20-F · filed 2020-06-24 | |
| 2017-03-31 | -22.37B JPY 20-F · filed 2019-06-27 |